In hemorrhagic stroke patients, the CCL5 levels measured at every time point were significantly lower than those obtained in healthy subjects (p ≤ 0.001), with no significant differences among times (Figure 1). The gene discussed is CCL5; the disease is hemorrhagic stroke.